The approval is for both a 3 milliliter (mL) single-patient-use prefilled pen and a 10 milliliter ... The FDA granted approval of Merilog to Sanofi-Aventis U.S. LLC. “The FDA has now approved three ...

The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj ... Both a 3-mL single-patient-use prefilled pen and a 10-mL multiple-dose vial are included ...

This disposable insulin pen is to be used for the treatment of ... the name of the parent company was changed globally from sanofi-aventis to Sanofi in May 2011.On 9 October 2012, Sanofi India ...

On February 14, 2025, the U.S. Food and Drug Administration (“FDA”) approved Sanofi-Aventis ... pen and a 10 mL multiple-dose vial. Sanofi’s MERILOG™ is now the first insulin aspart ...

The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

(RTTNews) - The U.S. Food and Drug Administration announced that Sanofi-Aventis U.S ... use prefilled pen and a 10 mL multiple-dose vial. As a rapid-acting human insulin, Merilog helps to lower ...

Sanofi-Aventis' Merilog version ... options for costly treatments, like insulin." Merilog has been cleared in a 3ml single-patient-use prefilled pen, and a 10ml multiple-dose vial should be ...

vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension and 30% insulin as part injection (rDNA origin) pen fill ...

WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj ... of Merilog was granted to Sanofi-Aventis.